1Spacek J, Jilek P,et al.Antifungal immunity and its mechanism in female genitalia [J]. Ceska Gynekol, 2004,69(2):133 - 140.
2Taylor B N, Saavedra M, Fidel P L J. Local Th1/Th2 Cytokine production during experimental vaginal candidiasis potential Importance of transforming growth factor-beta [J].Med Mycol,2000,38(6):419 - 431.
3Wormley E L J, Chaiban J, Fidel P L J. Cell adhesion molecule and Lymphocyte activation marker expression during experimental Vaginal candidiasis [J]. Infecs Lmmun, 2001,69(8):5072 - 5079.
4Nawrot V, Grzybek H K, Zielska V, et al. The study of cell mediated immune response in recurrent Vulvovaginal candidiasis[J]. FEMs Lmmunol Med Microbiol,2000,29(2) :89- 94.
5Ghaleb M, Hamad M, Abu E K H. Vaginal T Lymphocye population kinetics during experimental vaginal: candidosis evidence for a possible role of CD8^+ T ceils in protection against vaginal candidosis [J]. Clin Exp Lmmunol, 2003, 131(1):26-33.
6Sobel J D. Recurrent Vulvovaginal candidasis (RVVC) [J].International Jour of STD&AIDS,2001,2:9.
7Sobel J D. Pathogenesis of RVVC[J]. Curr Infect Dis Rep,2002,4(6) :514- 519.
8Barousse M I.Vaginal yeast colonisation prevalence of vaginitis and associated local immunity in adolescents [J].Sexually Transmit ted Lmfection, 2004,80(1) :48 - 53.
9David A .Chronic vulvovaginal candidiasis[J]. New England Jour of Medicine,2004,351(24) :2554 - 2556.
10Egan M E, Lipsky.Diagnosis of vaginitis [J].Am Fam physician, 2000,62(5):1095 - 1104.
